
LifeLens: Leading in innovative biotech devices for personal health monitoring.
LifeLens Technologies, founded in 2023, is a biotechnology company dedicated to pioneering innovative devices for personal health monitoring. Their core mission is to enhance individual health management through advanced, user-friendly technology. LifeLens focuses on developing next-generation treatment devices, such as their flagship product, the LifeLens Wireless ECG Monitor, designed for patients who may be asymptomatic or suffer from various cardiac conditions. The company aims to revolutionize personal health monitoring by making it more accessible and efficient.
Notable figures affiliated with LifeLens Technologies include leading experts in biotechnology and healthcare innovation. The company has garnered attention from prominent investors in the health tech sector, underscoring its potential for significant impact. Key achievements include the successful development and deployment of their wireless ECG monitor, which has received positive feedback for its accuracy and ease of use. LifeLens Technologies continues to make strides in personal health monitoring, contributing to improved patient outcomes and setting new standards in the industry.

LifeQ
lifeq.com

LifeSignals
lifesignals.com

Life365
life365.health

MediTrak Life
meditrak.life

Ventricle Health Tech

AffirmXH
affirmxh.com

Fetal Life
fetallife.com

Vital Connect
vitalconnect.com

BioSense
thebiosense.com

GraphWear Technologies

Praesidium
biofi.tech

BioscanR

Vivalink
vivalink.com

Life Detection Technologies

AliveCor
alivecor.com
Companies similar to LifeLens Technologies include LifeQ, LifeSignals, Life365 and MediTrak Life.
LifeLens Technologies was founded in 2014.
LifeLens Technologies' headquarters is located in Warminster, PA, US.
LifeLens Technologies' most recent funding round was for $3.2M (USD) in August 2020.
As of Aug 4, 2020, LifeLens Technologies has raised a total of $3.2M (USD).
LifeLens Technologies has 50 employees as of Feb 5, 2024.